Exelixis (EXEL) News Today $44.81 +0.75 (+1.70%) Closing price 04:00 PM EasternExtended Trading$44.80 -0.01 (-0.02%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EXEL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Stephens Inc. AR Acquires 64,459 Shares of Exelixis, Inc. (NASDAQ:EXEL)July 16 at 4:34 AM | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Purchased by Cerity Partners LLCJuly 16 at 4:07 AM | marketbeat.comExelixis (EXEL): Analyst Raises Price Target to $56 with Buy Rating | EXEL Stock NewsJuly 15 at 12:54 PM | gurufocus.comTruist Financial Boosts Exelixis (NASDAQ:EXEL) Price Target to $56.00July 15 at 11:56 AM | marketbeat.comExelixis to Release Second Quarter 2025 Financial Results on Monday, July 28, 2025July 14 at 4:05 PM | businesswire.comExelixis (NASDAQ:EXEL) Given New $43.00 Price Target at UBS GroupJuly 14 at 8:43 AM | marketbeat.comWall Street Brunch: Big Banks Kick Off Earnings SeasonJuly 13 at 3:44 PM | seekingalpha.comExelixis, Inc. (NASDAQ:EXEL) is Stephens Investment Management Group LLC's 6th Largest PositionJuly 13 at 6:26 AM | marketbeat.comNisa Investment Advisors LLC Acquires 45,060 Shares of Exelixis, Inc. (NASDAQ:EXEL)July 13 at 4:43 AM | marketbeat.comAssessing Exelixis: Insights From 12 Financial AnalystsJuly 12, 2025 | benzinga.comBanque Pictet & Cie SA Makes New $537,000 Investment in Exelixis, Inc. (NASDAQ:EXEL)July 11, 2025 | marketbeat.comConcurrent Investment Advisors LLC Takes $457,000 Position in Exelixis, Inc. (NASDAQ:EXEL)July 11, 2025 | marketbeat.comBank of New York Mellon Corp Grows Position in Exelixis, Inc. (NASDAQ:EXEL)July 11, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Earns "Sector Perform" Rating from Royal Bank Of CanadaJuly 11, 2025 | americanbankingnews.comExelixis (EXEL) Receives Price Target Upgrade from Barclays | EXEL Stock NewsJuly 10, 2025 | gurufocus.comExelixis (NASDAQ:EXEL) Price Target Raised to $40.00July 10, 2025 | marketbeat.comBarclays Increases Price Target for Exelixis (EXEL) Amid Colorectal Cancer Progress | EXEL ...July 10, 2025 | gurufocus.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Teacher Retirement System of TexasJuly 10, 2025 | marketbeat.comPenserra Capital Management LLC Makes New $1.30 Million Investment in Exelixis, Inc. (NASDAQ:EXEL)July 9, 2025 | marketbeat.comPrincipal Financial Group Inc. Sells 14,218 Shares of Exelixis, Inc. (NASDAQ:EXEL)July 9, 2025 | marketbeat.comExelixis (NASDAQ:EXEL) Downgraded by Royal Bank Of Canada to "Sector Perform"July 8, 2025 | marketbeat.comExelixis: I Was Wrong To Be Too Cautious (Rating Upgrade)July 8, 2025 | seekingalpha.comExelixis Target of Unusually Large Options Trading (NASDAQ:EXEL)July 8, 2025 | americanbankingnews.comStock Traders Buy High Volume of Call Options on Exelixis (NASDAQ:EXEL)July 7, 2025 | marketbeat.comEULAV Asset Management Raises Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)July 7, 2025 | marketbeat.comWhat is Zacks Research's Estimate for Exelixis Q4 Earnings?July 6, 2025 | americanbankingnews.comExelixis, Inc. (NASDAQ:EXEL) Shares Acquired by KBC Group NVJuly 5, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Buys New Shares in Exelixis, Inc. (NASDAQ:EXEL)July 5, 2025 | marketbeat.comPeering Into Exelixis's Recent Short InterestJuly 4, 2025 | benzinga.com2 Stocks to Buy With Less Than $50July 4, 2025 | fool.comResearch Analysts Set Expectations for Exelixis Q4 EarningsJuly 4, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by New York State Teachers Retirement SystemJuly 4, 2025 | marketbeat.comZacks Industry Outlook Highlights Exelixis, Verona Pharma, Alkermes, Kiniska Pharmaceuticals and ImmunocoreJuly 3, 2025 | finance.yahoo.comExelixis (NASDAQ:EXEL) Trading 6.4% Higher - Should You Buy?July 3, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Meritage Portfolio ManagementJuly 3, 2025 | marketbeat.comWhat is Zacks Research's Estimate for Exelixis Q1 Earnings?July 3, 2025 | marketbeat.comAmalgamated Bank Sells 8,226 Shares of Exelixis, Inc. (NASDAQ:EXEL)July 3, 2025 | marketbeat.comAsset Management One Co. Ltd. Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)July 1, 2025 | marketbeat.comHC Wainwright Increases Exelixis (NASDAQ:EXEL) Price Target to $53.00June 30, 2025 | marketbeat.comExelixis’s Promising STELLAR-303 Trial Results Lead to Buy Rating and Increased Approval ProbabilityJune 30, 2025 | tipranks.comMonument Capital Management Acquires New Position in Exelixis, Inc. (NASDAQ:EXEL)June 30, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Grows Stake in Exelixis, Inc. (NASDAQ:EXEL)June 30, 2025 | marketbeat.comCambridge Investment Research Advisors Inc. Grows Position in Exelixis, Inc. (NASDAQ:EXEL)June 30, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Given Average Rating of "Moderate Buy" by BrokeragesJune 29, 2025 | marketbeat.com3 No-Brainer Stocks to Buy for Under $100 Right NowJune 28, 2025 | fool.comNuScale, Hims & Hers, Snowflake, Advance Auto Parts, Exelixis: Trending by AnalystsJune 28, 2025 | tipranks.comRobeco Institutional Asset Management B.V. Buys 100,240 Shares of Exelixis, Inc. (NASDAQ:EXEL)June 28, 2025 | marketbeat.comFlagship Harbor Advisors LLC Takes Position in Exelixis, Inc. (NASDAQ:EXEL)June 27, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Increases Holdings in Exelixis, Inc. (NASDAQ:EXEL)June 27, 2025 | marketbeat.comExelixis (NasdaqGS:EXEL) Reports Positive Phase 3 Trial Results For Colorectal CancerJune 26, 2025 | finance.yahoo.com Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address EXEL Media Mentions By Week EXEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXEL News Sentiment▼0.690.97▲Average Medical News Sentiment EXEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXEL Articles This Week▼2216▲EXEL Articles Average Week Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News BioMarin Pharmaceutical News Exact Sciences News Repligen News Halozyme Therapeutics News Ionis Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXEL) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.